Unraveling the clinicopathological features driving the emergence of ESR1 mutations in metastatic breast cancer

ESR1 mutations were recently found to be an important mechanism of endocrine resistance in ER-positive (ER + ) metastatic breast cancer. To determine the clinicopathological features driving the emergence of the ESR1 mutations we studied plasma cfDNA and detailed clinical data collected from patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuang, Yanan, Siddiqui, Bilal, Hu, Jiani, Pun, Matthew, Cornwell, MacIntosh, Buchwalter, Gilles, Hughes, Melissa E., Wagle, Nikhil, Kirschmeier, Paul, Jänne, Pasi A., Paweletz, Cloud P., Lin, Nancy U., Krop, Ian E., Barry, William T., Winer, Eric P., Brown, Myles, Jeselsohn, Rinath
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6072793/
https://www.ncbi.nlm.nih.gov/pubmed/30083595
http://dx.doi.org/10.1038/s41523-018-0075-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6072793/
https://www.ncbi.nlm.nih.gov/pubmed/30083595
http://dx.doi.org/10.1038/s41523-018-0075-5

Ejemplares similares